【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2014
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 The Human Tissue Banking Market – Our Definition
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015-2025
3.1 The World Biobanking for Medicine Market in 2014
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2019 and 2025
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015-2025
3.4 Biobanks Stored Around 1.3 Billion Specimens in 2014
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015-2025
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015-2025
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015-2025
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015-2025
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2014
4.2 Biobanking for Research in 2019 and 2025: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015-2025
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2014
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015-2025
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015-2025
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015-2025
4.8 The Stem Cell Banking Market for Research in 2014
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015-2025
4.9.1 R&D – Growing Interest towards iPSCs
4.10 Banking of Other Biologic Specimens for Research in 2014
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015-2025
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2014: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2019 and 2025
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2014
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015-2025
5.7 The Adult Stem Cell Banking Market in 2014
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015-2025
6. Leading National Markets 2015-2025
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2014
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015-2025
6.4 How Will Regional Market Shares Change to 2025?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015-2025: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015-2025: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2025
6.8.1 The Chinese Biobanking Market 2015-2025: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015-2025: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015-2025: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015-2025?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated With Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability and Easy Sample Tracking
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2014
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services from Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2015-2025
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015-2025
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015-2025
10. Research Interviews from Our Survey – 2015
10.1 Dr Jeanne-Hélène di Donato, 3C-R, France
10.1.1 French Biobanks – a Network of Specialized Biobanks
10.1.2 Biobanking Management –Promoting Scientific Value of Collections
10.1.3 Harmonization – Scientific Valorisation
10.1.4 Bioethical – Diverse Views and Policies on Consent
10.1.5 Broad Consent –Is This the Best Option?
10.1.6 3C-R – Services and Solutions for Biobanks
10.2 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.2.1 UK ME/CFS Biobank – Objectives and Activities
10.2.2 Biobank Resource – Available for External Researchers in August 2015
10.2.3 Main Issue – Sustainability
10.2.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2015-2025: High Revenue Growth Predicted
11.2 Biobanking for Research 2015-2025: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015-2025: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：医療バイオバンクの世界市場：組織バンク、幹細胞バンク（臍帯血幹細胞バンク、成体幹細胞バンク）■ 英文：Biobanking for Medicine: Technology, Industry and Market 2015-2025
■ 発行日：2015年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN50615
■ 調査対象地域：グローバル
- ハイパースペクトルイメージングの世界市場Over the last few years, the Global Hyperspectral Imaging Market has witnessed an increasing adoption of HSI technologies in ophthalmology, surface tissue and mucosal membrane analysis, gastrointestinal tract, and vascular system are driving the growth of this market. The growth of the hyperspectral imaging technologies market is also driven by factors, such as an increasing adoption of HSI techno …
- 航空機用アクチュエータ装置の世界市場About Aviation Actuator Systems Actuators control a wide range of applications in an aircraft. Almost every movable part in an aircraft has actuators; for example, actuators extend and retract landing gears. They are also used to control and limit velocity and engine speed by adjusting levers and flaps. Different sources of energy such as electric current, hydraulic fluid pressure, or pneumatic pr …
- 自動車用オイルフィルターの世界市場About Automotive Oil Filter market An automotive oil filter is a device designed to remove impurities and undesired components from the circulating engine oil. Engine oil lubricates the engine and needs to be freed from the particles that may increase the friction against the piston movement and hence reduces the efficiency of the engine. Canister-type filters are the most commonly used automotive …
- 航空宇宙産業用ロボットの世界市場2018-2022About Aerospace Robotics The scope of the report includes revenue generated by sales to manufacturers in the aerospace industry, including aerospace component manufacturers. Technavio’s analysts forecast the global aerospace robotics market to grow at a CAGR of 5.33% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the global ae …
- 世界の水力発電市場動向2013Update：市場規模、競争環境、規制、投資動向Hydropower (Large Hydro, Small Hydro and Pumped Storage), 2013 Update - Global Market Size, Competitive Landscape, Regulations and Investment Analysis to 2020 Summary “Hydropower (Large Hydro, Small Hydro and Pumped Storage), 2013 Update - Global Market Size, Competitive Landscape, Regulations and Investment Analysis to 2020” is the latest report from GlobalData, the industry analysis specialists …
- ソリッドコントロール装置の世界市場：シェール・シェーカー及びスクリーン、マッド遠心分離機、ハイドロサイクロン、マッドクリーナーThis report estimates the solids control equipment market, in terms of revenue. The market has been segmented into equipment types (Shale shakers & screen, Mud Centrifuges, Hydrocyclones, Mud cleaner, and others), applications (onshore & offshore), and regions (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America). Solids control equipment plays a vital role in the dril …
- Italian Hospital Microbiology Testing Market 2014This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian microbiology disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. &nbs …
- 悪性中皮腫：グローバル臨床試験レビュー（2014年上半期）Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and …
- Comstock Resources, Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 皮膚がん治療ワクチンの世界市場及びパイプラインインサイトSkin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used for first-line treatment have modest efficacy which lays emphasis on the development of better products like …
- 世界の輸液ポンプ市場：インスリンポンプ、経腸栄養ポンプInfusion pumps – new study showing you trends, R&D progress, and predicted revenues Where is the infusion pumps market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 216-page report provides 127 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. O …
- ウエハレベル製造装置の世界市場2016-2020About Wafer-Level Manufacturing Equipment The wafer-level manufacturing equipment is used for the production of semiconductor wafers, which includes processes such as lithography, etching and stripping, inspection, and packaging. The growing number of applications of semiconductor ICs across different segments has led to the increased demand for wafer-level manufacturing equipment. Technavio’s ana …
- 臭化水素酸の世界市場：用途及び地域別分析The global hydrobromic acid market is expected to grow at a CAGR of 6.4% from 2014 to 2019. The Asia-Pacific region holds the largest market share in the hydrobromic acid market, and is expected to grow at a CAGR of 5.2% during the forecast period. In this report, the hydrobromic acid market has been broadly classified on the basis of application and geography. The application segment is divided i …
- Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Operating Room Equipment market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data …
- Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Amyotrophic Lateral Sclerosis Therapeutics market. The report identifies the key trends shaping an …
